Healthcare resource utilization in first-line immunotherapies for patients with metastatic melanoma.

被引：0
|
作者：
Liu, Frank Xiaoqing
Klink, Andrew
Feinberg, Bruce A.
Ahsan, Sama
Nero, Damion
Chmielowski, Bartosz
机构：
[1] Merck & Co Inc, N Wales, PA USA
[2] Cardinal Hlth Specialty Solut, Dallas, TX USA
[3] Cardinal Hlth Specialty Solut, Dublin, OH USA
[4] Merck & Co Inc, Kenilworth, NJ USA
[5] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 08期
关键词：
D O I：
10.1200/JCO.2019.37.8_suppl.137
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib plus trametinib versus nivolumab or pembrolizumab monotherapy
    Ghate, Sameer R.
    Ionescu-Ittu, Raluca
    Burne, Rebecca
    Ndife, Briana
    Laliberte, Francois
    Nakasato, Antonio
    Duh, Mei Sheng
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (12) : 2169 - 2176
  • [2] Health Care Resource Utilization and Costs in First-Line Treatments for Patients with Metastatic Melanoma in the United States
    Klink, Andrew J.
    Chmielowski, Bartosz
    Feinberg, Bruce
    Ahsan, Sama
    Nero, Damion
    Liu, Frank Xiaoqing
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (08): : 869 - 877
  • [3] EFFECTIVENESS AND UTILIZATION OF FIRST-LINE IMMUNE CHECKPOINT INHIBITORS FOR PATIENTS WITH EXTRACRANIAL & INTRACRANIAL METASTATIC MELANOMA
    Lamba, Nayan
    Iorgulescu, Bryan
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A265 - A266
  • [4] Ipilimumab, nivolumab and tocilizumab as first-line therapy for advanced melanoma.
    Mehmi, Inderjit
    Hamid, Omid
    Hodi, F. Stephen
    Vassalo, Melinda
    Malatyali, Saundra
    Krishnarajapet, Swathi
    O'Donnell, Nan
    Castrence, Angeli
    Lim, Eunice
    Gormley, Jill
    Weber, Jeffrey S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Choice of first-line therapy in metastatic melanoma
    Gibney, Geoffrey T.
    Atkins, Michael B.
    [J]. CANCER, 2019, 125 (05) : 666 - 669
  • [6] Healthcare costs and resource utilization associated with select severe adverse events in patients with metastatic urothelial cancer treated with first-line systemic therapies
    Shenolikar, Rahul
    Laliberte, Francois
    Doleh, Yunes
    Cavanaugh, Cristi
    DerSarkissian, Maral
    Grivas, Petros
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 300 - 301
  • [7] REDUCED HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA ACHIEVING COMPLETE REMISSION TO FIRST-LINE THERAPY
    Enschede, S. Heitner
    Samp, J.
    Guerin, A.
    Foster, R.
    Meissner, B.
    Rokito, A.
    Gauthier, G.
    [J]. HAEMATOLOGICA, 2017, 102 : 425 - 426
  • [8] Healthcare resource utilization and costs in patients with HIV-1 who switched first-line antiretroviral therapy
    Mao, Jianbin
    Johnson, Michael P.
    McPheeters, Jeffrey T.
    Prajapati, Girish
    Beyer, Andrew P.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (11) : 1945 - 1953
  • [9] Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma
    Diab, Adi
    Tykodi, Scott S.
    Daniels, Gregory A.
    Maio, Michele
    Curti, Brendan D.
    Lewis, Karl D.
    Jang, Sekwon
    Kalinka, Ewa
    Puzanov, Igor
    Spira, Alexander, I
    Cho, Daniel C.
    Guan, Shanhong
    Puente, Erika
    Tuan Nguyen
    Hoch, Ute
    Currie, Sue L.
    Lin, Wei
    Tagliaferri, Mary A.
    Zalevsky, Jonathan
    Sznol, Mario
    Hurwitz, Michael E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (26) : 2914 - +
  • [10] Pembrolizumab as first-line treatment for metastatic uveal melanoma
    Ernesto Rossi
    Monica Maria Pagliara
    Daniela Orteschi
    Tommaso Dosa
    Maria Grazia Sammarco
    Carmela Grazia Caputo
    Gianluigi Petrone
    Guido Rindi
    Marcella Zollino
    Maria Antonietta Blasi
    Alessandra Cassano
    Emilio Bria
    Giampaolo Tortora
    Giovanni Schinzari
    [J]. Cancer Immunology, Immunotherapy, 2019, 68 : 1179 - 1185
12345